๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chengdu
Clinical trial register · China

Clinical Trials in Chengdu

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
West China Hospital162 AstraZeneca148 Janssen Research & Development, LLC55 Hoffmann-La Roche44 Sichuan University44
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
1291 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
NCT07665359Chronic Obstructive Pulmonary Disease (COPD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
630
Guangzhou, Wuhan, Nanchang, Shanghai, Chengdu, Hangzhou, Huzhou, Jiaxing
2026-07-01
By invitation
Non-surgical Management After NIT for dMMR/MSI-H GC
NCT07646574Non-surgical Management;dMMR/MSI-H Gastric Cancer;Neoadjuvant Immunotherapy
Yong Zhou
Observational
12
Chengdu
2026-07-01
By invitation
Acupuncture to Prevent Nausea and Vomiting After Stem Cell Transplant
NCT07747194Chemotherapy-Induced Nausea and Vomiting (CINV), Hematopoietic Stem Cell Transplantation (HSCT)
Xiao Wang
Not applicable
80
Chengdu
2026-07-01
By invitation
Compassionate Administration of ZVS101e for Extended Treatment
NCT07307469Bietti Crystalline Corneoretinal Dystrophy
Chigenovo Co., Ltd
Not applicable
32
Beijing, Guangzhou, Zhengzhou, Chengdu, Tianjin
2026-07
Not yet open
Different Pressure Tissue Flossing Combined With Exercise for Chronic Ankle Instability
NCT07667816Chronic Ankle Instability, Ankle Instability
Chengdu Sport University
Not applicable
48
Chengdu
2026-07
Not yet open
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
NCT07691515Intrahepatic Cholangiocarcinoma (Icc)
Zhejiang Cancer Hospital
Phase 3
140
Guangzhou, Jiangmen, Wuhan, Changsha, Ganzhou, Nanchang, Qingdao, Chengdu
2026-07
Recruiting
Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study
NCT07453381Coronary Microvascular Dysfunction (CMD)
Peking University Third Hospital
Observational
114
Beijing, Cangzhou, Chengdu
2026-06-30
Not yet open
Real-world Study on the Efficacy, Safety, and Prognostic Factors of Immune Checkpoint Inhibitors Combined With Radiotherapy in Patients With Malignant Tumors: A Prospective Non-interventional Clinical Study
NCT07665736Radiotherapy, Immune Checkpoint Inhibitors (ICIs)
Sichuan University
Observational
200
Chengdu
2026-06-30
Recruiting
Phase I Study of HRS-1635 in B-cell Malignancies
NCT07583212B-cell Malignancy
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
180
Chengdu
2026-06-30
Not yet open
Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study
NCT07665697Neoplasms, Drug Therapy, Immune Checkpoint Inhibitors (ICIs)
Sichuan University
Observational
500
Chengdu
2026-06-30
Not yet open
A Phase Ib Study of Tislelizumab Plus SYS6010 in Immunotherapy-Pretreated Locally Advanced or Metastatic NSCLC
NCT07692048NSCLC
Sichuan University
Phase 1
21
Chengdu
2026-06-30
Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
NCT07667803Weight Management
AstraZeneca
Phase 3
4,500
Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian
2026-06-29
Recruiting
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC
NCT07572864Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 2
9
Chengdu
2026-06-29
Recruiting
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
NCT07604766Platinum-resistant Ovarian Cancer
Genmab
Phase 3
82
Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jinan
2026-06-26
Recruiting
A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
NCT07774403Bronchiectasis With Pseudomonas Aeruginosa Colonization
AstraZeneca
Phase 2
84
Anyang, Beijing, Changsha, Chengdu, Chizhou, Haikou, Hefei, Hohhot
2026-06-24
Recruiting
Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
NCT07593248Lung Cancer
AstraZeneca
Observational
2,000
Beijing, Chengdu, Fuzhou, Guangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang
2026-06-22
Not yet open
Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested Growth
NCT07669545Infantile Hemangioma (IH)
West China Hospital
Observational
150
Chengdu
2026-06-20
Recruiting
Chatbot Intervention Effects on Social and Monetary Incentive Processing in Anhedonia
NCT07665242Healthy
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Recruiting
Chatbot Intervention Effects on Emotional Arousal in Anhedonia
NCT07671131Healthy
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Not yet open
Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer
NCT07637786Advanced Pancreatic Adenocarcinoma
Sichuan University
Phase 1
9
Chengdu
2026-06-20
Recruiting
Chatbot Intervention Effects on Resting-State Brain Function in Anhedonia
NCT07665216Healthy
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Recruiting
Chatbot Intervention Effects on Belief Updating in Anhedonia
NCT07663019Healthy
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-06-20
Recruiting
Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions
NCT07371182Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital
Not applicable
62
Hefei, Nanning, Guiyang, Zunyi, Nanchang, Xi'an, Chengdu, รœrรผmqi
2026-06-19
Not yet open
A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)
NCT07579949Thalassemia
ScinnoHub Pharmaceutical Co., Ltd.
Phase 2
30
Foshan, Guangzhou, Maoming, Liuzhou, Nanning, Haikou, Chengdu
2026-06-18
Not yet open
EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT
NCT07674199Patients After Hematopoietic Stem Cell Transplantation
The General Hospital of Western Theater Command
Phase EARLY_PHASE1
20
Chengdu
2026-06-18
Recruiting
Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NCT07726953Acute Respiratory Distress Syndrome
Southeast University, China
Not applicable
500
Beijing, Changchun, Chengdu, Chenzhou, Dalian, Fuzhou, Guangzhou, Hangzhou
2026-06-16
Recruiting
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Observational
1,776
Beijing, Fuzhou, Nanjing, Jinan, Chengdu, Hangzhou, Changchun, Chenzhou
2026-06-16
Recruiting
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
NCT07656909Kaposiform Hemangioendothelioma (KHE), Kasabach Merritt Phenomenon
Yi Ji
Phase 2/3
76
Chengdu
2026-06-16
Recruiting
Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis
NCT07567235Radiation-Induced Skin Fibrosis, Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 1
9
Chengdu
2026-06-15
Recruiting
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
NCT07606937Relapsed/Refractory Large B-cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase EARLY_PHASE1
12
Beijing, Guangzhou, Suzhou, Shanghai, Chengdu, Tianjin
2026-06-12
Active, closed
Clinical Investigation of Oral Malodor for Max Fresh Toothpaste Containing Zinc Citrate Versus a Commercially Available Regular Fluoride Toothpaste
NCT07398378Oral Malodor
Colgate Palmolive
Phase 3
80
Chengdu
2026-06-12
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Lanzhou, Nanchang, Nanjing
2026-06-11
Recruiting
Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients
NCT07510308pMMR/MSS Advanced Colorectal Cancer
West China Hospital
Phase 1
9
Chengdu
2026-06-11
Recruiting
Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
NCT07516184Suspected Asthma
AstraZeneca
Not applicable
500
Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Guangzhou, Kunming, Quanzhou
2026-06-10
Recruiting
Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
NCT07635277Radiation-Induced Skin Injury
West China Hospital
Phase 1
40
Chengdu
2026-06-07
Not yet open
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
NCT07560124Breast Cancer
Akeso
Phase 1/2
286
Beijing, Harbin, Chengdu
2026-06-06
Recruiting
GB06 Phase III Trial for Pediatric Growth Hormone Deficiency
NCT07553351Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric
Kexing Biopharm Co., Ltd.
Phase 3
192
Chengdu
2026-06-06
Recruiting
Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors
NCT07567222Malignant Tumor
West China Hospital
Phase 1
54
Chengdu
2026-06-05
Recruiting
Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT07744087Ampullary Carcinoma, Duodenal Adenocarcinoma, Distal Cholangiocarcinoma
Nanfang Hospital, Southern Medical University
Not applicable
232
Chongqing, Guangzhou, Chengdu, Jiancheng
2026-06-04
Active, closed
Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer
NCT07635290Previously Treated, Advanced, Biliary Tract Cancers
West China Hospital
Phase 2
26
Chengdu
2026-06-03
Recruiting
Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
NCT07676773Diabete Type 2, Cardio Respiratory Fitness
Sichuan Academy of Medical Sciences
Not applicable
80
Chengdu
2026-06-01
Active, closed
LLMs Improve Patient Understanding of Ultrasound Reports
NCT07647536Patient Understanding of Ultrasound Reports
Lu Wang
Not applicable
660
Chengdu
2026-06-01
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis
R1 Therapeutics
Phase 2
168
Beijing, Zhengzhou, Nanjing, Shanghai, Chengdu
2026-06-01
Not yet open
Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas
NCT07616323LUMBAR Syndrome
West China Hospital
Observational
70
Chengdu
2026-06-01
Recruiting
Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
NCT07489573Hidradenitis Suppurativa (HS)
Novartis Pharmaceuticals
Phase 4
36
Guangzhou, Shijiazhuang, Chengdu, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2026-06-01
Not yet open
WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)
NCT07615894Advanced Solid Tumors, Malignant Pleural Effusions, Malignant Ascites
WestVac Biopharma Co., Ltd.
Phase 1
9
Chengdu
2026-06-01
Not yet open
Treatment of Recurrent/Metastatic Head and Neck Cancer
NCT07601204Recurrent/Metastatic Head and Neck Cancer
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1/2
128
Beijing, Guangzhou, Nanning, Wuhan, Changsha, Shenyang, Taiyuan, Chengdu
2026-06
Not yet open
Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars
NCT07620769Acne Scars, Acne Scars - Atrophic, Acne Scar, Acne Scarring
CLASSYS Inc.
Not applicable
252
Chengdu, Chongqing, Hebei, Shanghai
2026-06
Recruiting
Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer
NCT07636798Biliary Tract Cancer
West China Hospital
Phase 1/2
20
Chengdu
2026-06
Not yet open
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
NCT07644234Ischemic Stroke, Transient Ischemic Attack
Sichuan Provincial People's Hospital
Phase 4
3,836
Chengdu
2026-06
Not yet open
Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)
NCT07610434IBS, Diarrhea Predominant
Beijing Hospital of Traditional Chinese Medicine
Phase 3
636
Beijing, Chengdu, Chongqing, Guangzhou, Guizhou, Haozhou, Hebei, Heilongjiang
2026-05-31
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT07518186Multiple Myeloma
Janssen Research & Development, LLC
Phase 3
700
Beijing, Changchun, Chaoyang District, Chengdu, Guangzhou, Nanchang, Shenzhen, Tianjin
2026-05-31
Not yet open
Muscle Ultrasound for Sarcopenia Assessment in Kidney Transplant Recipients
NCT07607236Sarcopenia, Kidney Transplantation, Muscle Wasting
Sichuan Provincial People's Hospital
Observational
140
Chengdu
2026-05-30
Not yet open
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
NCT07582822Advanced Solid Tumor
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Recruiting
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
NCT07463521Ocular Myasthenia Gravis
UCB Biopharma SRL
Phase 3
120
Beijing, Chengdu, Nanchang, Suzhou
2026-05-27
Recruiting
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants
NCT07550816Overweight,Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
60
Chengdu
2026-05-27
Recruiting
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
NCT07513441Parkinson Disease
H. Lundbeck A/S
Phase 1
10
Beijing, Shanghai Shi, Chengdu
2026-05-26
Recruiting
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
NCT07279935Non-small Cell Lung Cancer
AstraZeneca
Phase 4
100
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2026-05-26
Recruiting
Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain
NCT07491146Pain After Abdominal Surgery
Yingyong Zhou,MD,PhD
Phase 2
200
Changsha, Chengdu
2026-05-23
Recruiting
A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery
NCT07533786Pain After Surgery
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
200
Changsha, Chengdu
2026-05-22
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT07413939HER2-positive Breast Cancer
Hoffmann-La Roche
Phase 2/3
650
Nanjing, Shanghai, Beijing, Bengbu, Chengdu, Fuzhou, Guangzhou, HangzhouZhejiang
2026-05-21
Recruiting
CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
NCT07612774Coronary, Coronary Artery Disease
West China Hospital
Phase 4
233
Chengdu
2026-05-19
Recruiting
A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.
NCT07483970High Risk Non-muscle Invasive Bladder Cancer
Jecho Biopharmaceuticals Co., Ltd.
Phase 1
18
Chengdu
2026-05-18
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Recruiting
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal Surgery
NCT07709598Postoperative Pain
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 2/3
330
Chengdu
2026-05-11
Recruiting
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma
NCT07492914Resectable Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 2
30
Chengdu
2026-05-11
Recruiting
Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC
NCT07565740HPV-positive Oropharyngeal Squamous Cell Carcinoma
West China Hospital
Phase 1
9
Chengdu
2026-05-10
Recruiting
Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming for Advanced Solid Tumors
NCT07563972Advanced Solid Tumors, Neoplasm
West China Hospital
Phase 1
9
Chengdu
2026-05-10
Active, closed
Prevalence of Pelvic Venous Congestion Syndrome in Female Patients With Lower Extremity Varicose Veins and Its Impact on Postoperative Quality of Life Improvement Following Radiofrequency Ablation: A Single-Center Prospective Cohort Study๏ผˆPCSRFStudy๏ผ‰
NCT07680465Pelvic Venous Congestion Syndrome, Lower Limb Varicose Veins, Radiofrequency Ablation
Chengdu University of Traditional Chinese Medicine
Observational
300
Chengdu
2026-05-08
Recruiting
Dymista in Chinese Adolescents
NCT07597473Allergic Rhinitis Due to Allergens
Viatris Inc.
Phase 4
100
Beijing, Changsha, Chengdu, Dalian, Hangzhou, Nanchang, Shanghai, Taiyuan
2026-05-08
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
NCT07545759Irritable Bowel Syndrome, Diarrhea
Eli Lilly and Company
Phase 2
531
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-05-06
Recruiting
YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment
NCT07409805Colorectal Cancer
West China Hospital
Phase 1
9
Chengdu
2026-05-06
Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412Metastatic Colorectal Cancer
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Guangzhou, Nanning, Wuhan, Nanjing, Chengdu, Hangzhou
2026-05-06
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Not yet open
5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region
NCT07551063Hepatic Echinococcosis
West China Hospital
Phase EARLY_PHASE1
10
Chengdu
2026-05-01
Not yet open
A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma
NCT07578506Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
West China Hospital
Phase 1
9
Chengdu
2026-05-01
Not yet open
Intranasal Dexmedetomidine for Prevention of Intrapartum Fever
NCT07501221Intrapartum Fever
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
446
Chengdu
2026-05-01
Not yet open
Intranasal Dexmedetomidine for Postpartum Depression Prevention
NCT07501728Postpartum Depression (PPD)
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
270
Chengdu
2026-05-01
Recruiting
Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy
NCT07746323Ipsilateral Shoulder Pain, Lung Neoplasms
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
270
Chengdu
2026-05-01
Not yet open
Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC
NCT07561983Unresectable Stage III Non-small Cell Lung Cancer, Tislelizumab, Chemotherapy, Chemoembolization, Therapeutic
Sichuan Cancer Hospital and Research Institute
Phase 2
39
Chengdu
2026-05-01
Not yet open
The Comparison Between DEDTI BR and T/E BR
NCT07593846Breast Cancer
West China Hospital
Phase 3
412
Chengdu
2026-05-01
Not yet open
Study on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke
NCT07507097Stroke Acute
West China Hospital
Not applicable
1,508
Chengdu
2026-05-01
Not yet open
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
NCT07590596Pulmonary Nodule, Suspected Lung Cancer, Preoperative Decision-Making
Sichuan Cancer Hospital and Research Institute
Observational
200
Chengdu
2026-05
Not yet open
The Effect of Acupuncture Therapy on Cognitive Function in Post-COVID-19 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NCT07357688Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Xi Wu
Not applicable
99
Chengdu
2026-05
Not yet open
The Effect of Acupuncture Treatment on Cognitive Functions and Brain Networks for Long COVID
NCT07355751Long Covid
Tingting Luo
Not applicable
108
Chengdu
2026-05
Recruiting
IMP3-saRNA Vaccine in Advanced NSCLC
NCT07561723Non-Small Cell Lung Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-30
Recruiting
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
NCT07571161Alzheimer Disease
Eli Lilly and Company
Phase 3
140
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei
2026-04-30
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
NCT07545772Irritable Bowel Syndrome, Constipation
Eli Lilly and Company
Phase 2
342
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-04-29
Recruiting
Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
NCT07562841Advanced Melanoma
West China Hospital
Phase 1
6
Chengdu
2026-04-28
Recruiting
Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors
NCT07560943Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Not yet open
Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors
NCT07562815Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
NCT07416604Hemophilia A
Hoffmann-La Roche
Phase 3
360
Guangzhou, Chengdu, Tianjin
2026-04-27
Recruiting
Oxytocin's Effects on Real Time-fMRI Neurofeedback Training of Anterior Insula Activity
NCT07559656Healthy
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-04-26
Recruiting
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
NCT07520162Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca
Phase 3
230
Beijing, Bengbu, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Foshan
2026-04-24
Recruiting
Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
NCT07545967Head and Neck Squamous Cell Carcinoma HNSCC
West China Hospital
Phase 1
6
Chengdu
2026-04-23
Recruiting
CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms
NCT07519187Relapsed or Refractory Plasma Cell Neoplasms
The General Hospital of Western Theater Command
Phase EARLY_PHASE1
20
Chengdu
2026-04-23
Active, closed
Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations
NCT07338942ATTR-CM
AstraZeneca
Not applicable
4,000
Beijing, Changlexi, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangdong Province
2026-04-21
Recruiting
A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer
NCT07518173HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
596
Guangzhou, Chengdu
2026-04-21
Not yet open
A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children
NCT07511920Muscular Dystrophy, Becker, Muscular Dystrophy, Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne
West China Second University Hospital
Observational
500
Chengdu
2026-04-20
Recruiting
Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)
NCT07538479Solid Tumors, Solid Malignancies, Cold Exposure, Immunotherapy
West China Hospital
Phase 1
24
Chengdu
2026-04-20
Rows per page Showing 101–200 of 1291
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/chengdu?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.